Spyre Therapeutics, Inc. (SYRE): 10-Q filed Aug 4, 2026

Form type

10-Q

Filing date

Aug 4, 2026

Accession number

0001636282-26-000096

Filer

Spyre Therapeutics, Inc. (CIK 1636282)